DiaMedica Appoints Dr. Todd Verdoorn as Vice President of Neuroscience

MINNEAPOLIS, MINNESOTA–(Marketwired – Jan. 20, 2016) – DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (“DiaMedica”), today announced the appointment of Dr. Todd Verdoorn as DiaMedica’s Vice President of Neuroscience. Dr. Verdoorn has more than 26 years of experience working with both public and private companies to develop new treatments for neurological diseases, including five years working with Bristol-Myers Squibb’s stroke group.Dr. Verdoorn earned his PhD in Neurobiology from the University of North Carolina, conducting his post-doctoral research at the Max Planck Institute with Nobel Laureate Dr. Bert Sakmann and served as Associate Professor of Pharmacology at Vanderbilt University School of Medicine.”We are pleased to welcome Dr. Verdoorn to our team,” said Rick Pauls, President & Chief Executive Officer of DiaMedica. “His knowledge and experience in stroke will help DiaMedica as we focus our…


Link to Full Article: DiaMedica Appoints Dr. Todd Verdoorn as Vice President of Neuroscience